Identification of Cysteine-Reactive Early Mitotic Inhibitors
Cancer remains a pervasive health problem for millions of Americans, and defining effective anticancer therapeutics remains a major obstacle to the long-term survival of patients. Recent advances in novel chemistries and chemical libraries have enabled researchers to discover and develop covalent inhibitors to treat various diseases, including cancer. This has spurred the generation of…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
